AbCellera Biologics Inc.ABCLNASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank71
5Y CAGR-67.9%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
-67.9%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
202510.91%
2024-7.84%
2023-191.07%
20220.00%
202175.00%
20203206.80%
2019-615.00%
20180.00%